Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
Advertisement
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Online Letters to the Editor

Comment on: Song et al. (2009) Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women

A Randomized, Controlled Trial. Diabetes 58:1921–1928

  1. Po-Yuan Chang1,
  2. Shao-Chun Lu2,
  3. Yuan-Teh Lee3 and
  4. Chu-Huang Chen3,4,5
  1. 1Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan;
  2. 2Department of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan;
  3. 3Department of Medicine, China Medical University Hospital, Taichung, Taiwan;
  4. 4Vascular and Medicinal Research, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas;
  5. 5Department of Medicine, Baylor College of Medicine, Houston, Texas.
  1. Corresponding author: Chu-Huang Chen, cchen{at}heart.thi.tmc.edu.
Diabetes 2010 Mar; 59(3): e1-e1. https://doi.org/10.2337/db09-1543
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

The Diabetes article by Song et al. (1) presents the results of the first randomized, controlled trial to analyze the long-term effects of folic acid and vitamin B supplementation on the risk of developing type 2 diabetes in women at high risk for cardiovascular disease. Daily supplements significantly lowered homocysteine levels but did not reduce the risk of developing type 2 diabetes. Their results do not support previous findings indicating increased homocysteine levels as a significant predictor of the development of diabetes (2).

These conflicting data must be viewed in light of the increasing evidence gained from clinical trials, which suggests no beneficial effects of homocysteine-lowering strategies on cardiovascular events (3). Given the controversy, it has been suggested that S-adenosylhomocysteine (SAH), the cytotoxic precursor of homocysteine, may be a more sensitive indicator of cardiovascular disease than is homocysteine (4). We have recently studied the mechanisms by which homocysteine and SAH cause endothelial cell damage (5). In our study, human coronary artery endothelial cells were unaffected by exposure to homocysteine, even at supraphysiologic concentrations (500 μmol/l); however, low concentrations (25 μmol/l) of homocysteine induced cytotoxic changes in endothelial cells under culture conditions that increased the intracellular level of SAH (5). We believe our findings show that in the absence of SAH, the vascular effects of homocysteine may be negligible.

These findings may help explain the lack of health benefits observed in several nutritional intervention trials, including that of Song et al. (1). Vitamin supplements that successfully lower homocysteine levels may not affect SAH levels. It would be of interest to see a large-scale, prospective study of SAH, rather than homocysteine, as an indicator of the development of diabetes.

ACKNOWLEDGMENTS

This study was supported in part by research grant 1-04-RA-13 from the American Diabetes Association; grants NSC 91-2320-B-002-185, 93-2314-B-002-125, 94-2320-B-002-121, 95-2320-B-002-116, and 98-2628-B-002-088-MY3 from the National Science Council, Taiwan; and grants NTUH92A14, 93A02, 95S342, and 96S643 from the National Taiwan University Hospital, Taiwan.

No potential conflicts of interest relevant to this article were reported.

The authors thank Rebecca Bartow, PhD, of the Texas Heart Institute at St. Luke's Episcopal Hospital for editorial assistance.

  • © 2010 by the American Diabetes Association.

REFERENCES

  1. ↵
    1. Song Y,
    2. Cook NR,
    3. Albert CM,
    4. Van Denburgh M,
    5. Manson JE
    : Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes 2009; 58: 1921– 1928
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Cho NH,
    2. Lim S,
    3. Jang HC,
    4. Park HK,
    5. Metzger BE
    : Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. Diabetes Care 2005; 28: 2750– 2755
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Lonn E
    : Homocysteine-lowering B vitamin therapy in cardiovascular prevention—wrong again? JAMA 2008; 299: 2086– 2087
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Wagner C,
    2. Koury MJ
    : S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr 2007; 86: 1581– 1585
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Chang PY,
    2. Lu SC,
    3. Lee CM,
    4. Chen YJ,
    5. Dugan TA,
    6. Huang WH,
    7. Chang SF,
    8. Liao WS,
    9. Chen CH,
    10. Lee YT
    : Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008; 102: 933– 941
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Advertisement

In this Issue

March 2010, 59(3)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comment on: Song et al. (2009) Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
Citation Tools
Comment on: Song et al. (2009) Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women
Po-Yuan Chang, Shao-Chun Lu, Yuan-Teh Lee, Chu-Huang Chen
Diabetes Mar 2010, 59 (3) e1; DOI: 10.2337/db09-1543

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Comment on: Song et al. (2009) Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women
Po-Yuan Chang, Shao-Chun Lu, Yuan-Teh Lee, Chu-Huang Chen
Diabetes Mar 2010, 59 (3) e1; DOI: 10.2337/db09-1543
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Response to Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134
  • Comment on: Sitnick et al. Skeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity. Diabetes 2013;62:3350–3361
  • Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134
Show more Online Letters to the Editor

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • For Advertisers
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org
Advertisement

© 2019 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.